A patch of protection against Zika virus
A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.
Credit: UQ
A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne...
Human Glia Reprogrammed into Neuron-Generating Cells
In humans and other mammals, loss of neurons in the retina due to trauma or disease is an irreversible process that can lead to blindness. But unlike humans, some animals, such as fish, have...
Could an Alzheimer’s vaccine make treatment more affordable?
Alzheimer’s research has come a long way since the disease was first identified more than a century ago. Now, as treatments have been developed to reduce the harmful proteins in the brain that are...
C-Path’s TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics
Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet...
Scientists create framework to guide development and assessment of urban climate action plans
With the world projected to be highly urbanized by 2050, cities are encouraged to take urgent climate actions to mitigate and adapt to the threats of climate change. As climate change intensifies and urbanization...
Insilico Medicine hosts three webinars to unveil latest technology breakthroughs
Insilico Medicine ("Insilico"), an artificial intelligence (AI)-driven, clinical stage biotechnology company and leader in AI drug discovery platform technology, is hosting three webinars unveiling its latest technology breakthroughs Nov. 28-30, 2023. These new features...
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be...
Multi-Chambered Heart Organoids Allow Study of Organ Development and Defects
Scientists at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences have developed a multi-chamber organoid that mirrors the heart’s intricate structure. The human cardioid platform recapitulates the development of all...
Understanding rapid tendon regeneration in newts may one day help human athletes
A research group led by Nagoya University’s Graduate School of Engineering has uncovered how rapid tendon regeneration occurs in newts. The research, published in the Journal of Orthopaedic Research, compared the regeneration mechanism of...
New heart organoid model could revolutionize drug development and toxicology studies
Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid that...
